Summary
The interaction between sufentanil, a μ-opioid agonist, and the Ca2+ antagonist nimodipine on respiration and on the development of opioid tolerance in awake rats has been analyzed. Our previous work demonstrated that chronic treatment with nimodipine together with sufentanil increases the analgesic potency of the opioid 50 fold. Therefore, we have investigated whether the opioid-induced respiratory depression is potentiated in parallel with the analgesia. Ventilation was measured by the whole body plethysmographic method. In naive rats, sufentanil (10–80 μg/kg) consistently induced a dose-dependent respiratory depression. Pretreatment with nimodipine (200 μg/kg) potentiated this effect but to a lesser extent than it potentiated analgesia. After chronic administration of the opioid (2 μg/h, 7 days) tolerance was manifested as a reduction in both the area under the time course curve and in the maximum effect. Nimodipine (1 μg/h) administered concurrently with sufentanil for 7 days counteracted the tolerance to respiratory depression but no additional potentiation was observed. These results demonstrate that the interaction between nimodipine and sufentanil is not limited to antinociception but also exends to respiratory depression. However, compared with analgesia, the clinical relevance of a potential increase in opioid-induced respiratory depression by nimodipine may be negligible.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ayesta FJ (1991) Tolerance and physical dependence: physiological manifestations of chronic exposure to opioids. In: Almeida OFX, Shippenberg TS (eds) Neurobiology of opioids. Springer, Berlin Heidelberg New York, pp 387–405
Ayesta FJ, Flórez J (1989) Tolerance to respiratory actions of sufentanil: Functional tolerance and route-dependent differential tolerance. J Pharmacol Exp Ther 250:371–378
Ayesta FJ, Flórez J (1990) Tolerance to the respiratory actions of opiates: withdrawal tolerance and asymmetrical cross-tolerance. Eur J Pharmacol 175:1–12
Baeyens JM, del Pozo E (1988) Interactions between calcium channel blockers and non-cardiovascular drugs: interactions with drugs acting at the neuromuscular or the CNS level. Pharmacol Toxicol 62:59–63
Baeyens JM, Esposito E, Ossowska G, Samanin R (1987) Effects of peripheral administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur J Pharmacol 137:9–13
Barlett D, Tenney SM (1970) Control of breathing in experimental anaemia. Respir Physiol 10:384–395
Benedek G, Szikszay M (1984) Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol Res Commun 16:1009–1018
Bold J, Von Borman B, Kling D, Russ W, Ratthey K, Hempelmann G (1987) Low-dose fentanyl analgesia modified by calcium channel blockers in cardiac surgery. Eur J Anaesthesiol 4:387–394
Bongianni F, Carla V, Moroni F, Pellegrini-Giampietro DE (1986) Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br J Pharmacol 88:561–567
Carta F, Bianchi M, Argenton S, Cervi D, Marolla G, Tamburini M, Breda M, Fantoni A, Panerai AE (1990) Effect of nifedipine on morphine-induced analgesia. Anesth Analg 70:493–498
Contreras E, Tamayo L, Amigo M (1988) Calcium antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur J Pharmacol 148:463–466
Dierssen M, Flórez J, Hurlé MA (1990) Calcium channel modulation by dihydropyridines modifies sufenatil-induced antinociception in acute and tolerant conditions. Naunyn Schmiedebergs Arch Pharmacol 342:559–565
Dierssen MM, Ruiz F, Flórez J, Hurlé MA (1991) Ca2+ channel modulation by dihydropyridines modifies sufentanil-induced respiratory depression in cats. Eur J Pharmacol 198:149–155
Flórez J, Hurlé MA (1993) Opioids in respiration and vomiting. In: Herz A (ed) Handbuch der Experimentellen Pharmacologie 104/II: Opioids. Springer, Berlin Heidelberg New York, pp 263–292
Flórez J, Dierssen MM, Hurlé MA (1989) Influence of nimodipine on the respiratory effect of sufentanil at the brain stem level. Adv Biosci 75:535–538
Hoffmeister F, Tettenborn D (1986) Calcium agonists and antagonists of the dihydropyridine type: antinociceptive effects, interference with opiate-μ-receptor angonists and neuropharmacological actions in rodents. Psychopharmacology 90:299–307
Kavaliers M (1987) Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity. Brain Res 408:403–407
Lehmann KA, Kriegel R, Ueki M (1989) The clinical significance of drug interactions between opiates and calcium antagonists. A randomized double-blind study using fentanyl and nimodipine within the framework of postoperative intravenous on-demand analgesia. Anaesthetist 38:110–115
Morin-Surun MP, Boudinot E, Gacel G, Champagnat J, Roques BP, Denavit-Saubié M (1984) Different effect of μ and δ opiate agonists on respiration. Eur J Pharmacol 98:235–240
Pasternak GW, Wood PJ (1986) Multiple mu opiate receptors. Life Sci 38:1889–1898
Roerig SC, Fujimoto JM, Lange DG (1987) Development of tolerance to respiratory depression in morphine- and morphine-pellet-implanted mice. Brain Res 400:278–284
Santillán R, Maestre JM, Hurlé MA, Flórez J (1993) Nimodipine, a calcium channel blocker, potentiates opiate analgesia in patients with cancer pain tolerant to morphine. In: Proc 7th World Congress on Pain, International Association for the study of pain Publications, Seattle, p 335
Szikszay M, Synder FR, London ED (1986a) Interactions between verapamil and morphine on physiological parameters in rats. J Pharmacol Exp Ther 238:192–197
Szikszay M, Synder FR, London ED (1986b) Effects of diltiazem on morphine-induced respiratory decline. J Pharm Pharmacol 38:625–627
Tallarida RJ, Murray RB (1981) Manual of pharmacologic calculations. Springer, New York Berlin Heidelberg
Van den Hoogen RHWM, Colpaert FC (1986) Respiratory effect of morphine in awake unrestraind rats. J Pharmacol Exp Ther 237:252–259
Yeadon M, Kitchen I (1989) Opioids and respiration. Prog Neurobiol 33:1–16
Author information
Authors and Affiliations
Additional information
Correspondence to: M. A. Hurlé at the above address
Rights and permissions
About this article
Cite this article
Ruiz, F., Dierssen, M., Flórez, J. et al. Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats. Naunyn-Schmiedeberg's Arch Pharmacol 348, 633–637 (1993). https://doi.org/10.1007/BF00167240
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167240